175 related articles for article (PubMed ID: 33388329)
1. Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system.
Malone C; Buist DSM; Tiro J; Barlow W; Gao H; Lin J; Winer RL
Prev Med; 2021 Apr; 145():106410. PubMed ID: 33388329
[TBL] [Abstract][Full Text] [Related]
2. Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid.
Parekh N; Donohue JM; Men A; Corbelli J; Jarlenski M
Obstet Gynecol; 2017 Jan; 129(1):66-75. PubMed ID: 27926644
[TBL] [Abstract][Full Text] [Related]
3. Is Immigrant Status Associated With Cervical Cancer Screening Among Women in Canada? Results From a Cross-Sectional Study.
Bacal V; Blinder H; Momoli F; Wu KY; McFaul S
J Obstet Gynaecol Can; 2019 Jun; 41(6):824-831.e1. PubMed ID: 30361160
[TBL] [Abstract][Full Text] [Related]
4. Tubal Sterilization and Cervical Cancer Underscreening in the United States.
Holt HK; Martinez G; Reyes MF; Saraiya M; Qin J; Sawaya GF
J Womens Health (Larchmt); 2024 Jun; 33(6):729-733. PubMed ID: 38502830
[No Abstract] [Full Text] [Related]
5. Women with obesity in cervical cancer screening. The double penalty: Underscreening and income inequalities.
Sassenou J; Ringa V; Zins M; Ozguler A; Paquet S; Panjo H; Franck JE; Menvielle G; Rigal L
Obes Res Clin Pract; 2021; 15(3):212-215. PubMed ID: 33771444
[TBL] [Abstract][Full Text] [Related]
6. Patterns and correlates of cervical cancer screening initiation in a large integrated health care system.
Becerra-Culqui TA; Lonky NM; Chen Q; Chao CR
Am J Obstet Gynecol; 2018 Apr; 218(4):429.e1-429.e9. PubMed ID: 29277629
[TBL] [Abstract][Full Text] [Related]
7. Underscreening, overscreening, and guideline-adherent cervical cancer screening in a national cohort.
Lee YW; Morgan JR; Fiascone S; Perkins RB
Gynecol Oncol; 2022 Nov; 167(2):181-188. PubMed ID: 36150914
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
9. Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013-2014.
Luque JS; Tarasenko YN; Chen C
J Prim Prev; 2018 Aug; 39(4):329-344. PubMed ID: 29876723
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with underscreening for cervical cancer among women in Canada.
Schoueri-Mychasiw N; McDonald PW
Asian Pac J Cancer Prev; 2013; 14(11):6445-50. PubMed ID: 24377548
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
12. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
Nuño T; Castle PE; Harris R; Estrada A; García F;
J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
[TBL] [Abstract][Full Text] [Related]
13. Utilization patterns of cervical cancer screening in Italy.
Barbadoro P; Ricciardi A; Di Tondo E; Vallorani S; Mazzarini G; Prospero E
Eur J Cancer Prev; 2015 Mar; 24(2):135-40. PubMed ID: 24977627
[TBL] [Abstract][Full Text] [Related]
14. Immigration and Adherence to Cervical Cancer Screening: A Provincewide Longitudinal Matched Cohort Study Using Multistate Transitional Models.
Lee F; Paszat LF; Sutradhar R
J Obstet Gynaecol Can; 2019 Jun; 41(6):813-823. PubMed ID: 31130182
[TBL] [Abstract][Full Text] [Related]
15. Cervical Cancer Screening Knowledge, Perceptions, and Behaviors in a Multiracial Cohort of Low-Income, Underscreened Women in North Carolina.
Bukowski A; Smith JS; Wheeler SB; Sanusi B; McGuire FH; Zeno E; Des Marais AC; Barclay L; Hudgens MG; Jackson S; Brewer NT
J Womens Health (Larchmt); 2023 Sep; 32(9):970-981. PubMed ID: 37327372
[No Abstract] [Full Text] [Related]
16. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk?
Coughlin SS; Uhler RJ; Hall HI; Briss PA
Prev Chronic Dis; 2004 Jan; 1(1):A04. PubMed ID: 15634366
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening practices among older women: results from the Maryland Cervical Cancer Case-Control Study.
Celentano DD; Klassen AC; Weisman CS; Rosenshein NB
J Clin Epidemiol; 1988; 41(6):531-41. PubMed ID: 3385455
[TBL] [Abstract][Full Text] [Related]
18. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with cervical cancer screening in Puerto Rico.
Ortiz AP; Hebl S; Serrano R; Fernandez ME; Suárez E; Tortolero-Luna G
Prev Chronic Dis; 2010 May; 7(3):A58. PubMed ID: 20394697
[TBL] [Abstract][Full Text] [Related]
20. Physician recommendation for papanicolaou testing among U.S. women, 2000.
Coughlin SS; Breslau ES; Thompson T; Benard VB
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
